What is the Role of Cutaneous Lymphocyte Antigen in the Pathogenesis of Behçet’s Disease: A Randomized, Prospective Double-Blinded Study
DOI:
https://doi.org/10.12970/2310-998X.2016.04.01.2Keywords:
Behçet’s Disease, CLA, Immunology, Pathogenesis.Abstract
Background: Behcet’s Disease (BD) is a chronic systemic vasculitis of unknown etiology. Cutaneous lymphocyte antigen (CLA) has an important role in the migration of T cells into the inflamed skin.
Objective: Our aim was to investigate the relationship between CLA+T cell and clinical activity of BD.
Methods: A total of 80 Behçet patients and 20 healthy controls were involved in this study. BD patients were divided into four groups: ocular group genital ulcer group vessel/skin lesion group, inactive group. 10.000 cells in peripheral blood were used to assess the expression levels of CD3, CD4, CD8, CLA+CD4 and CLA+CD8 in lymphocytes with CLA/FITC clone HECA-452 kit.
Results: Erythrocyte sedimentation rate, C-reactive protein and lymphocyte CLA+CD8 levels were found to be higher, whereas CD4/CD8 and CLA+CD4/CLA+CD8 ratios were found lower in patients with BD when compared to controls.
Conclusions: CLA may be an important finding in the determination of etiopathogenesis, disease activity and prognosis of BD.
References
Behcet H. Über rezidiverende, aphtöse durch ein virus verursachte Geschwerü am munt, am auge und an den genitalien. Dermatol Wochenschr 1937; 105: 1152-1157.
Önder M, Gürer MA. The multiple faces of Behçet’s disease and its aetiological factors. J Eur Acad Dermatol Venereol 2001; 15: 126-36. http://dx.doi.org/10.1046/j.1468-3083.2001.00251.x
Evereklioğlu C. Current consept in the etiology and treatment of Behçet disease. Surv Ophthalmol 2005; 50: 297-350. http://dx.doi.org/10.1016/j.survophthal.2005.04.009
Borlu M. Behçet hastalığında etyopatogenez. Saglık Bilimleri Dergisi 2007; 16: 63-72.
Campbell DE, Kemp AS. Cutaneous lymphocyte-associated antigen expression in children with atopic dermatitis and non-atopic healty children. Pediatr Allergy Immunol 1999; 10: 253-257. http://dx.doi.org/10.1034/j.1399-3038.1999.00042.x
Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L, Storey H. IL-31 is associated with cutaneous lymphocyte antigen–positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006; 117: 418-425. http://dx.doi.org/10.1016/j.jaci.2005.10.046
Lee SY, Shim JY, Kim JH, Kim BS, Seo HJ, Choi SO, Jang SO, Hong SJ. Cyclosporine treatment decreases the percentage of cutaneous lymphocyte antigen (CLA) + CD4+ T cells in children with severe atopic dermatitis. Allergy 2004; 59: 1129-1130. http://dx.doi.org/10.1111/j.1398-9995.2004.00639.x
Teraki Y, Hotta T, Shiohara T. Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis. Br J Dermatol 2000; 143: 373. http://dx.doi.org/10.1046/j.1365-2133.2000.03665.x
Sigmundsdottır H, Gudjonsson JE, Jonsdottır I, Ludviksson BR, Valdimarsson H. The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 2001; 126: 365-369. http://dx.doi.org/10.1046/j.1365-2249.2001.01688.x
International study group for Behçet’s disease. Criteria for diagnosis of Behcet’s disease. Lancet 1990; 335: 1078-1080.
Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, Tunç R, Urgancioğlu M, Dişçi R. The prevalance of Behcet’s disease in İstanbul, Turkey. Int J Dermatol 2003; 42: 803-806. http://dx.doi.org/10.1046/j.1365-4362.2003.01893.x
Cakir N, Dervis E, Benian O, Pamuk ON Sonmezates N, Rahimoglu R, Tuna S, Cetin T, Sarikaya Y. Prevalance of Behçet’s disease in rural western Turkey: A preliminary report. Clin Exp Rheumatol 2004; 22: 53-55.
Borlu M, Ukşal Ü, Ferahbaş A, Evereklioğlu C. Clinical features of Behçet’s disease in children. Int J Dermatol 2006; 45: 713-716. http://dx.doi.org/10.1111/j.1365-4632.2006.02754.x
Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S. Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study. J Am Acad Dermatol 2008; 58(4): 579-584. http://dx.doi.org/10.1016/j.jaad.2007.10.452
Ozkul Y, Evereklioglu C, Borlu M, Taheri S, Calis M, Dündar M, Ilhan O. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. Br J Ophthalmol 2005; 89(12): 1634-1637. http://dx.doi.org/10.1136/bjo.2005.076836
Calis M, Ates F, Yazici C, Kose K, Kirnap M, Demir M, Borlu M, Evereklioglu C. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease. Rheumatol Int 2005; 25(6): 452-456. http://dx.doi.org/10.1007/s00296-005-0612-z
Santamaria-Babi LF. CLA+ T cells in cutaneous diseases. Eur J Dermatol 2004; 14: 13-18.
Magro CM, Dyrsen ME. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates. J Cutan Pathol 2008; 35: 1040-1049. http://dx.doi.org/10.1111/j.1600-0560.2007.00971.x
Ferran M, Gimenez-Arnau AM, Bellosillo B, Pujol RM, Santamaria-Babi LF. Effector function of CLA+ T lymphocytes on autologous keratinocytes in psoriasis. Actas Dermosifiliogr 2008; 99: 701-707. http://dx.doi.org/10.1016/S0001-7310(08)76174-X
Chang ST, Liao YL, Lin SH, Chuang SS. NK-cell lymphoma with nodal presentation and expression of cutaneous lymphocyte-associated antigen. Pathol Res Practice 2010; 206(7): 463-466. http://dx.doi.org/10.1016/j.prp.2009.07.001
Antúnez C, Torres MJ, López S, Rodriguez-Pena R, Blanca M Mayorga C, Santamaría-Babi LF. Calcitonin gene-related peptide modulates interleukin-13 in circulating cutaneous lymphocyte-associated antigen-positive T cells in patients with atopic dermatitis. Br J Dermatol 2009; 161: 547-553. http://dx.doi.org/10.1111/j.1365-2133.2009.09318.x
Salomon J, Baran E. The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol 2008; 22(2): 223-228.
